Evaluation of the Design, Development, and Performance of a Mass-Flow Based, Open-Source Buffer Manufacturing System

References

1. 1.↵
   BioPhorum. NIIMBL-BioPhorum Buffer Stock Blending System: A More Advanced Concept for Buffer Manufacturing. 2019. https://www.biophorum.com/wp-content/uploads/bp_downloads/NIIMBL-BioPhorum-buffer-stock-blending-system_-a-more-advanced-concept-for-buffer-manufacturing-December-2019.pdf
2. 2.↵
   GE Healthcare. Single-Use Technology and Sustainability: Quantifying the Environmental Impact in Biologic Manufacturing. 2017. https://cdn.cytivalifesciences.com/dmm3bwsv3/AssetStream.aspx?mediaformatid=10061&destinationid=10016&assetid=16801
3. 3.↵
   1. Haigney S.

   The Importance of Buffers in Downstream Processing. BioPharm Int. 2016, 29 (4), 26–29.

   OpenUrl
4. 4.↵
   1. Langer E. S.,
   2. Rader R. A.

   Powders and Bulk Liquids Economics of Large-Scale Culture Media and Buffer Preparation Are Changing. BioProcess Int. 2014, 12 (3), 10–16.

   OpenUrl
5. 5.↵
   1. Jacquemart R.,
   2. Vandersluis M.,
   3. Zhao M.,
   4. Sukhija K.,
   5. Sidhu N.,
   6. Stout J.

   A Single-Use Strategy to Enable Manufacturing of Affordable Biologics. Comput. Struct. Biotechnol. J. 2016, 14, 309–318.

   OpenUrl
6. 6.↵
   1. Jagschies G.,
   2. Lindskog E.,
   3. Łącki K.,
   4. Galliher P.

   1. Carredano E. N.,
   2. Nordberg R.,
   3. Westin S.,
   4. Busson K.,
   5. Karlsson T. M.,
   6. Blank T. S.,
   7. Sandegren H.,
   8. Jagschies G.

   Simplification of Buffer Formulation and Improvement of Buffer Control with In-Line Conditioning (IC). In Biopharmaceutical Processing; Jagschies G., Lindskog E., Łącki K., Galliher P., Eds.; Elsevier Ltd, 2018.
7. 7.↵
   1. Fabbrini D.,
   2. Simonini C.,
   3. Lundkvist J.,
   4. Carredano E.,
   5. Otero D.

   Addressing the Challenge of Complex Buffer Management an in-Line Conditioning Collaboration. BioProcess Int. 2017, 15 (11), 43–46.

   OpenUrl
8. 8.↵
   1. Tsai A.,
   2. Carredano E.,
   3. Busson K.

   Deploying Automated Buffer Production for cGMP Use: Points to Consider. BioProcess. J. 2019, 18, 1–14.

   OpenUrl
9. 9.↵
   1. Malone T.,
   2. Li M.

   PAT-Based In-Line Buffer Dilution. BioProcess Int. 2009, 7 (7), 68.

   OpenUrl
10. 10.↵
    1. Matthews T.,
    2. Bean B.,
    3. Mulherkar P.,
    4. Wolk B.

    An Integrated Approach to Buffer Dilution and Storage. Pharmamanufacturing 2009, 1–14.
11. 11.↵
    1. Mantle J. L.,
    2. Lee K. H.

    NIIMBL-Facilitated Active Listening Meeting between Industry and FDA Identifies Common Challenges for Adoption of New Biopharmaceutical Manufacturing Technologies. PDA J. Pharm. Sci. Technol. 2020, 74 (5), 497–508.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    BioPhorum. An Economic Evaluation of Buffer Preparation Philosophies for the Biopharmaceutical Industry; 2019. https://www.biophorum.com/wp-content/uploads/bp_downloads/An-economic-evaluation-of-buffer-preparation-philosophies-for-the-biopharmaceutical-industry-December-2019.pdf
13. 13.↵
    1. Coffman J.,
    2. Brower M.,
    3. Connell-Crowley L.,
    4. Deldari S.,
    5. Farid S. S.,
    6. Horowski B.,
    7. Patil U.,
    8. Pollard D.,
    9. Qadan M.,
    10. Rose S.,
    11. Schaefer E.,
    12. Shultz J.

    A Common Framework for Integrated and Continuous Biomanufacturing. Biotechnol. Bioeng. 2021, 118 (4), 1735–1749.

    OpenUrl
14. 14.↵
    1. Goklen K. E.,
    2. Suda E. J..,
    3. Ubiera A. R.

    Buffer System for Protein Purification. US Patent 9,624,261 B2, 2017.
15. 15.↵
    1. Rawlings B.,
    2. Pora H.

    Environmental Impact of Single-Use and Reusable Bioprocess Systems. BioProcess Int. 2009, 7 (2), 18–25.

    OpenUrl
16. 16.↵
    1. Sinclair A.,
    2. Leveen L.,
    3. Monge M.,
    4. Lim J.,
    5. Cox S.

    The Environmental Impact of Disposable Technologies. BioPharm Int. 2008, 21 (11 Suppl), 4–15.

    OpenUrl